Clinical Trials Update:&nbsp;Dec. 15, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
589264
Panacos releases more clinical trial results for an exciting drug.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
723616
Pfizer Inc. on Monday announced a major clinical trial of its Celebrex arthritis drug to gauge its possible cardiovascular benefits for osteoarthritis patients.
712506
GlaxoSmithKline Plc announced further  clinical trial results on Sunday underlining the ability of a  drug combination including its product Tykerb to fight breast  cancer that has spread to the brain.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
402115
Two drugs provide good results in preliminary trials.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
438501
Here's what a newly approved drug looks like.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
80442
The US Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.&#39;s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
594161
Genzyme announces positive study results with a recently acquired drug.
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.